Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Nov;151(5):1281–1288.

Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice.

N L McCartney-Francis 1, D E Mizel 1, M Frazier-Jessen 1, A B Kulkarni 1, J B McCarthy 1, S M Wahl 1
PMCID: PMC1858095  PMID: 9358754

Abstract

Mice homozygous for a nonfunctional transforming growth factor-beta 1 gene develop rampant inflammation in vital organs that contributes to a shortened life span. The presence of circulating anti-nuclear anti-bodies, immune deposits in tissues, leukocyte infiltration, and increased major histocompatibility complex antigen expression resembles an autoimmune-like syndrome. One of the overt symptoms that appears in these mice lacking transforming growth factor-beta 1 is the development of dry crusty eyes that close persistently as their health declines. Histologically, the eyes appear normal with little or no inflammation. However, inflammatory lesions, predominantly lymphocytic, develop in the lacrimal glands, disrupting their structure and function and severely limiting their ability to generate tears. This histopathology and aberrant function mimic that of Sjögren's syndrome, a human autoimmune disease characterized by dry eyes and dry mouth. Impeding the leukocyte infiltration into the glands with synthetic fibronectin peptides, which block adhesion, not only prevents the inflammatory pathology but also prevents the persistent eye closure characteristic of these mice.

Full text

PDF

Images in this article

1283Figure 1
on p.1283
1284Figure 2
on p.1284
1285Figure 3
on p.1285
1285Figure 4
on p.1285
1286Figure 5
on p.1286

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Smith C. W., Ward P. A. Adhesion molecules and inflammatory injury. FASEB J. 1994 May;8(8):504–512. [PubMed] [Google Scholar]
  2. Boumba D., Skopouli F. N., Moutsopoulos H. M. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol. 1995 Apr;34(4):326–333. doi: 10.1093/rheumatology/34.4.326. [DOI] [PubMed] [Google Scholar]
  3. Brennan F. M., Feldmann M. Cytokines in autoimmunity. Curr Opin Immunol. 1992 Dec;4(6):754–759. doi: 10.1016/0952-7915(92)90057-l. [DOI] [PubMed] [Google Scholar]
  4. Christ M., McCartney-Francis N. L., Kulkarni A. B., Ward J. M., Mizel D. E., Mackall C. L., Gress R. E., Hines K. L., Tian H., Karlsson S. Immune dysregulation in TGF-beta 1-deficient mice. J Immunol. 1994 Sep 1;153(5):1936–1946. [PubMed] [Google Scholar]
  5. Dang H., Geiser A. G., Letterio J. J., Nakabayashi T., Kong L., Fernandes G., Talal N. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol. 1995 Sep 15;155(6):3205–3212. [PubMed] [Google Scholar]
  6. Derynck R., Jarrett J. A., Chen E. Y., Goeddel D. V. The murine transforming growth factor-beta precursor. J Biol Chem. 1986 Apr 5;261(10):4377–4379. [PubMed] [Google Scholar]
  7. Dickson M. C., Martin J. S., Cousins F. M., Kulkarni A. B., Karlsson S., Akhurst R. J. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 1995 Jun;121(6):1845–1854. doi: 10.1242/dev.121.6.1845. [DOI] [PubMed] [Google Scholar]
  8. Diebold R. J., Eis M. J., Yin M., Ormsby I., Boivin G. P., Darrow B. J., Saffitz J. E., Doetschman T. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12215–12219. doi: 10.1073/pnas.92.26.12215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P., Blanchard J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985 Mar 11;13(5):1431–1442. doi: 10.1093/nar/13.5.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fox R. I., Bumol T., Fantozzi R., Bone R., Schreiber R. Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum. 1986 Sep;29(9):1105–1111. doi: 10.1002/art.1780290908. [DOI] [PubMed] [Google Scholar]
  11. Fox R. I., Kang H. I., Ando D., Abrams J., Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol. 1994 Jun 1;152(11):5532–5539. [PubMed] [Google Scholar]
  12. Gatherer D., Ten Dijke P., Baird D. T., Akhurst R. J. Expression of TGF-beta isoforms during first trimester human embryogenesis. Development. 1990 Oct;110(2):445–460. doi: 10.1242/dev.110.2.445. [DOI] [PubMed] [Google Scholar]
  13. Geiser A. G., Letterio J. J., Kulkarni A. B., Karlsson S., Roberts A. B., Sporn M. B. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9944–9948. doi: 10.1073/pnas.90.21.9944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hamano H., Saito I., Haneji N., Mitsuhashi Y., Miyasaka N., Hayashi Y. Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice. Eur J Immunol. 1993 Oct;23(10):2387–2391. doi: 10.1002/eji.1830231002. [DOI] [PubMed] [Google Scholar]
  15. Hartwell D., Levine J., Fenton M., Francis C., Leslie C., Beller D. Cytokine dysregulation and the initiation of systemic autoimmunity. Immunol Lett. 1994 Dec;43(1-2):15–21. doi: 10.1016/0165-2478(94)00144-8. [DOI] [PubMed] [Google Scholar]
  16. Hayashi Y., Haneji N., Hamano H. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice. Pathol Int. 1994 Aug;44(8):559–568. doi: 10.1111/j.1440-1827.1994.tb01716.x. [DOI] [PubMed] [Google Scholar]
  17. Hession C., Moy P., Tizard R., Chisholm P., Williams C., Wysk M., Burkly L., Miyake K., Kincade P., Lobb R. Cloning of murine and rat vascular cell adhesion molecule-1. Biochem Biophys Res Commun. 1992 Feb 28;183(1):163–169. doi: 10.1016/0006-291x(92)91623-x. [DOI] [PubMed] [Google Scholar]
  18. Hines K. L., Kulkarni A. B., McCarthy J. B., Tian H., Ward J. M., Christ M., McCartney-Francis N. L., Furcht L. T., Karlsson S., Wahl S. M. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5187–5191. doi: 10.1073/pnas.91.11.5187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hoffman R. W., Alspaugh M. A., Waggie K. S., Durham J. B., Walker S. E. Sjögren's syndrome in MRL/l and MRL/n mice. Arthritis Rheum. 1984 Feb;27(2):157–165. doi: 10.1002/art.1780270206. [DOI] [PubMed] [Google Scholar]
  20. Holers V. M., Ruff T. G., Parks D. L., McDonald J. A., Ballard L. L., Brown E. J. Molecular cloning of a murine fibronectin receptor and its expression during inflammation. Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J Exp Med. 1989 May 1;169(5):1589–1605. doi: 10.1084/jem.169.5.1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jabs D. A., Alexander E. L., Green W. R. Ocular inflammation in autoimmune MRL/Mp mice. Invest Ophthalmol Vis Sci. 1985 Sep;26(9):1223–1229. [PubMed] [Google Scholar]
  22. Jabs D. A., Enger C., Prendergast R. A. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci. 1991 Feb;32(2):371–380. [PubMed] [Google Scholar]
  23. Jabs D. A., Prendergast R. A. Ocular inflammation in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci. 1991 May;32(6):1944–1947. [PubMed] [Google Scholar]
  24. Jabs D. A., Prendergast R. A. Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med. 1987 Oct 1;166(4):1198–1203. doi: 10.1084/jem.166.4.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kaartinen V., Voncken J. W., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet. 1995 Dec;11(4):415–421. doi: 10.1038/ng1295-415. [DOI] [PubMed] [Google Scholar]
  26. Kessler H. S., Cubberly M., Manski W. Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjögren's syndrome. Arch Ophthalmol. 1971 Feb;85(2):211–219. doi: 10.1001/archopht.1971.00990050213016. [DOI] [PubMed] [Google Scholar]
  27. Konecki D. S., Brennand J., Fuscoe J. C., Caskey C. T., Chinault A. C. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res. 1982 Nov 11;10(21):6763–6775. doi: 10.1093/nar/10.21.6763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770–774. doi: 10.1073/pnas.90.2.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lee F., Yokota T., Otsuka T., Meyerson P., Villaret D., Coffman R., Mosmann T., Rennick D., Roehm N., Smith C. Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc Natl Acad Sci U S A. 1986 Apr;83(7):2061–2065. doi: 10.1073/pnas.83.7.2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Letterio J. J., Geiser A. G., Kulkarni A. B., Dang H., Kong L., Nakabayashi T., Mackall C. L., Gress R. E., Roberts A. B. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest. 1996 Nov 1;98(9):2109–2119. doi: 10.1172/JCI119017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Letterio J. J., Roberts A. B. Transforming growth factor-beta1-deficient mice: identification of isoform-specific activities in vivo. J Leukoc Biol. 1996 Jun;59(6):769–774. doi: 10.1002/jlb.59.6.769. [DOI] [PubMed] [Google Scholar]
  32. McCarthy J. B., Chelberg M. K., Mickelson D. J., Furcht L. T. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry. 1988 Feb 23;27(4):1380–1388. doi: 10.1021/bi00404a044. [DOI] [PubMed] [Google Scholar]
  33. McCarthy J. B., Vachhani B. V., Wahl S. M., Finbloom D. S., Feldman G. M. Human monocyte binding to fibronectin enhances IFN-gamma-induced early signaling events. J Immunol. 1997 Sep 1;159(5):2424–2430. [PubMed] [Google Scholar]
  34. McCartney-Francis N. L., Mizel D. E., Redman R. S., Frazier-Jessen M., Panek R. B., Kulkarni A. B., Ward J. M., McCarthy J. B., Wahl S. M. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol. 1996 Aug 1;157(3):1306–1312. [PubMed] [Google Scholar]
  35. McCartney-Francis N. L., Wahl S. M. Transforming growth factor beta: a matter of life and death. J Leukoc Biol. 1994 Mar;55(3):401–409. doi: 10.1002/jlb.55.3.401. [DOI] [PubMed] [Google Scholar]
  36. Millan F. A., Denhez F., Kondaiah P., Akhurst R. J. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development. 1991 Jan;111(1):131–143. doi: 10.1242/dev.111.1.131. [DOI] [PubMed] [Google Scholar]
  37. Miller D. A., Lee A., Matsui Y., Chen E. Y., Moses H. L., Derynck R. Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol. 1989 Dec;3(12):1926–1934. doi: 10.1210/mend-3-12-1926. [DOI] [PubMed] [Google Scholar]
  38. Miller D. A., Lee A., Pelton R. W., Chen E. Y., Moses H. L., Derynck R. Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol. 1989 Jul;3(7):1108–1114. doi: 10.1210/mend-3-7-1108. [DOI] [PubMed] [Google Scholar]
  39. Nakabayashi T., Letterio J. J., Geiser A. G., Kong L., Ogawa N., Zhao W., Koike T., Fernandes G., Dang H., Talal N. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice. J Immunol. 1997 Jun 1;158(11):5527–5535. [PubMed] [Google Scholar]
  40. Pepose J. S., Akata R. F., Pflugfelder S. C., Voigt W. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome. Ophthalmology. 1990 Dec;97(12):1599–1605. doi: 10.1016/s0161-6420(90)32372-2. [DOI] [PubMed] [Google Scholar]
  41. Proetzel G., Pawlowski S. A., Wiles M. V., Yin M., Boivin G. P., Howles P. N., Ding J., Ferguson M. W., Doetschman T. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet. 1995 Dec;11(4):409–414. doi: 10.1038/ng1295-409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Roberts A. B., Sporn M. B. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev. 1992 Jun;32(2):91–98. doi: 10.1002/mrd.1080320203. [DOI] [PubMed] [Google Scholar]
  43. Saito I., Terauchi K., Shimuta M., Nishiimura S., Yoshino K., Takeuchi T., Tsubota K., Miyasaka N. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal. 1993;7(3):180–187. doi: 10.1002/jcla.1860070309. [DOI] [PubMed] [Google Scholar]
  44. Schmid P., Cox D., Bilbe G., Maier R., McMaster G. K. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development. 1991 Jan;111(1):117–130. doi: 10.1242/dev.111.1.117. [DOI] [PubMed] [Google Scholar]
  45. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992 Oct 22;359(6397):693–699. doi: 10.1038/359693a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Silvera M. R., Sempowski G. D., Phipps R. P. Expression of TGF-beta isoforms by Thy-1+ and Thy-1- pulmonary fibroblast subsets: evidence for TGF-beta as a regulator of IL-1-dependent stimulation of IL-6. Lymphokine Cytokine Res. 1994 Oct;13(5):277–285. [PubMed] [Google Scholar]
  47. Siu G., Hedrick S. M., Brian A. A. Isolation of the murine intercellular adhesion molecule 1 (ICAM-1) gene. ICAM-1 enhances antigen-specific T cell activation. J Immunol. 1989 Dec 1;143(11):3813–3820. [PubMed] [Google Scholar]
  48. St Clair E. W., Angellilo J. C., Singer K. H. Expression of cell-adhesion molecules in the salivary gland microenvironment of Sjögren's syndrome. Arthritis Rheum. 1992 Jan;35(1):62–66. doi: 10.1002/art.1780350110. [DOI] [PubMed] [Google Scholar]
  49. Wahl S. M., Allen J. B., Hines K. L., Imamichi T., Wahl A. M., Furcht L. T., McCarthy J. B. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest. 1994 Aug;94(2):655–662. doi: 10.1172/JCI117382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wahl S. M., Feldman G. M., McCarthy J. B. Regulation of leukocyte adhesion and signaling in inflammation and disease. J Leukoc Biol. 1996 Jun;59(6):789–796. doi: 10.1002/jlb.59.6.789. [DOI] [PubMed] [Google Scholar]
  51. Ward P. A. Cytokines, inflammation, and autoimmune diseases. Hosp Pract (1995) 1995 May 15;30(5):35–41. doi: 10.1080/21548331.1995.11443197. [DOI] [PubMed] [Google Scholar]
  52. Wilson S. E., Lloyd S. A. Epidermal growth factor and its receptor, basic fibroblast growth factor, transforming growth factor beta-1, and interleukin-1 alpha messenger RNA production in human corneal endothelial cells. Invest Ophthalmol Vis Sci. 1991 Sep;32(10):2747–2756. [PubMed] [Google Scholar]
  53. Yaswen L., Kulkarni A. B., Fredrickson T., Mittleman B., Schiffman R., Payne S., Longenecker G., Mozes E., Karlsson S. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood. 1996 Feb 15;87(4):1439–1445. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES